New agents and regimens for diffuse large B cell lymphoma | Journal of Hematology & Oncology | Full Text
Cancers | Free Full-Text | Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions
Cancers | Free Full-Text | Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab
Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role? | Haematologica
Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
About RITUXAN® (rituximab) | Diffuse Large B Cell Lymphoma
Patient Information: Diffuse Large B Cell Lymphoma
Ibrutinib improves diffuse large B-cell lymphoma survival - NCI
Survival analysis in patients with diffuse large B-cell lymphoma... | Download Scientific Diagram
Prediction of Prognosis for Patients with Diffuse Large B-Cell Lymphoma Refractory to or in First Relapse After Initial R-CHOP Therapy: A Single-Institution Study | Anticancer Research
Diffuse Large B-Cell Lymphoma (DLBCL): Symptoms, Treatment and Prognosis – Nova Science Publishers
A: Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System - The ASCO Post
Novel model predicts prognosis for patients with diffuse large B-cell lymphoma in first relapse after initial R-CHOP therapy: a single-institution study in China - Wei Wang, Jingjing Yin, Wei Zhang, Yan Zhang,
Treatment resistance in diffuse large B-cell lymphoma | Leukemia
Frontiers | Real-World Estimation of First- and Second-Line Treatments for Diffuse Large B-Cell Lymphoma Using Health Insurance Data: A Belgian Population-Based Study
A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports
Diffuse large B-cell lymphoma: Early patient management | OTT
A modified prognostic model in patients with diffuse large B‑cell lymphoma treated with immunochemotherapy
Progression-free survival in diffuse large B cell lymphoma patients in... | Download Scientific Diagram
![PDF] Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/51a4a761ac9c47aeab4203b78043f3c50a5bbe83/2-Table1-1.png "PDF] Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era. | Semantic Scholar")
PDF] Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era. | Semantic Scholar
Outcomes of Autologous Hematopoietic Cell Transplantation in Diffuse Large B Cell Lymphoma Refractory to Firstline Chemoimmunotherapy - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular ...
B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort Study - eBioMedicine
Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy | Annals of Hematology
